Schedule 13G ownership disclosure
ALNYLAM PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 02043Q107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,032,656
- Percent of class
- 4.7700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001088875-24-000081
- Form type
- SC 13G
- Filer
- ALNYLAM PHARMACEUTICALS, INC.
- CIK
- CIK 1178670
- Filed
- Jul 05, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership